Clover Health Investments Corp. Class A (CLOV) Financials

$4.32

$0.02 (0.47%)

As on 02-Sep-2026 14:40EDT

Market cap

$2,247 Mln

Revenue (TTM)

$2,477 Mln

P/E Ratio

--

P/B Ratio

6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	2,476.71	1,924.31	1,371.13	1,260.54	1,096.55	1,472.00
Cost of Revenue	2,016.79	1,568.41	1,006.33	1,004.59	993.07	1,551.18
Gross Profit	459.93	355.88	364.80	255.95	103.48	-79.18
Operating Expenses	478.29	441.43	410.55	461.28	390.14	557.81
Operating Profit (EBIT)	-18.36	-85.53	-45.75	-205.33	-286.66	-636.99
Other Income	--	--	--	--	--	--
Profit before Tax	-18.36	-85.55	-46.27	-210.15	-254.58	-587.76
Provision for Tax	--	--	--	-208.54	-33.44	16.91
Profit after Tax (Net Income)	-18.36	-85.55	-43.01	-213.36	-339.57	-587.76
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-338.84	-587.76

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	376.26	308.70	341.14	286.39	356.89	535.41
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	20.74	23.48	26.08	23.16	20.23	38.86
Current Liabilities	323.33	208.82	213.52	261.12	431.51	372.62
Total Liabilities	1,043.66	541.01	580.74	570.67	808.62	950.80

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	234.88	233.16	237.62	142.70	183.62	198.26
Current Assets	485.45	307.86	343.12	427.97	625.00	752.55
Total Assets	1,043.66	541.01	580.74	570.67	808.62	950.80
Total Debt*	--	--	--	4.66	5.86	27.83
Net Current Assets	162.12	99.03	129.61	166.86	184.34	379.92

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-66.93	34.85	-115.87	-203.93	-282.33
Cash Flow from Investing Activities	--	4.08	0.57	140.01	95.13	-435.45
Cash from Financing Activities	--	-53.38	-17.36	-33.86	-4.96	925.39
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.04	-0.17	-0.09	-0.44	-0.71	-1.25
Cash EPS ($)	--	-0.16	-0.08	-0.44	-0.71	-1.25
Adjusted Book Value ($)	--	0.60	0.69	0.59	0.75	1.14
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.13	0.07	-0.24	-0.43	-0.60
Free Cash Flow per Share ($)	--	-0.13	0.07	-0.24	-0.44	-0.60

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-26.33	-13.61	-65.27	-73.34	-1,391.06
ROE (%)	-5.36	-26.33	-13.71	-66.34	-76.11	1,439.13
ROA (%)	-2.02	-15.25	-7.47	-30.94	-38.60	-96.51
EBIT Margin (%)	-0.74	-4.45	-3.37	-16.67	-23.09	-38.78
Net Margin (%)	-0.74	-4.45	-3.14	-16.93	-30.97	-39.93
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	54.03	0.40	0.09	0.15	-0.26	1.19
EBIT Growth (%)	56.95	-84.91	77.98	17.01	55.64	-620.00
Net Profit Growth (%)	57.40	-98.91	79.84	37.17	42.23	-330.93
EPS Growth (%)	53.73	-0.89	0.80	0.38	0.43	-2.70
Book Value Growth (%)	1.99	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-14.21	-36.02	-2.15	-1.31	-2.98
Price / Book Value	5.98	3.94	4.54	1.60	1.24	3.27
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.65	-13.36	-29.55	-1.09	-0.46	-2.04
Close Price ($)	5.24	2.35	3.15	0.95	0.93	3.72
High Price ($)	5.59	4.87	4.71	1.63	4.11	28.85
Low Price ($)	1.58	2.12	0.61	0.71	0.86	3.68
Market Cap ($ Cr)	2,246.79	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	0.02	0.02	0.05
Short term debt to equity ratio	--	--	--	0.01	0.01	0.01
Current Ratio	1.50	1.47	1.61	1.64	1.45	2.02
Quick Ratio	1.50	--	--	1.37	1.68	2.43
Interest Coverage	--	--	--	-30,020.14	-185.78	-33.76

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	8.19	8.25	6.77	6.84	15.28	7.43
Asset Turnover	2.72	3.43	2.38	1.83	1.25	2.42
Receivable days	--	23.87	23.85	36.77	46.13	24.11
Inventory Days	--	--	25.42	-5.79	-47.04	-42.61
Payable days	--	8.24	13.02	12.66	11.14	6.92
Cash Conversion Cycle	--	--	36.25	18.32	-12.05	-25.42

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.